DOCSLIB.ORG

Mouse Cmtm3 Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Cmtm3 Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Cmtm3 Knockout Project (CRISPR/Cas9) Objective: To create a Cmtm3 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Cmtm3 gene (NCBI Reference Sequence: NM_024217 ; Ensembl: ENSMUSG00000031875 ) is located on Mouse chromosome 8. 5 exons are identified, with the ATG start codon in exon 1 and the TAA stop codon in exon 5 (Transcript: ENSMUST00000034343). Exon 1~5 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 1 starts from about 0.18% of the coding region. Exon 1~5 covers 100.0% of the coding region. The size of effective KO region: ~6015 bp. The KO region does not have any other known gene. Page 1 of 9 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 3 4 5 Legends Exon of mouse Cmtm3 Knockout region Page 2 of 9 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of start codon is aligned with itself to determine if there are tandem repeats. Tandem repeats are found in the dot plot matrix. The gRNA site is selected outside of these tandem repeats. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section downstream of stop codon is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 9 https://www.alphaknockout.com Overview of the GC Content Distribution (up) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(27.4% 548) | C(17.85% 357) | T(18.5% 370) | G(36.25% 725) Note: The 2000 bp section upstream of start codon is analyzed to determine the GC content. Significant high GC-content regions are found. The gRNA site is selected outside of these high GC-content regions. Overview of the GC Content Distribution (down) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(27.65% 553) | C(24.95% 499) | T(23.25% 465) | G(24.15% 483) Note: The 2000 bp section downstream of stop codon is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 4 of 9 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr8 + 104338750 104340749 2000 browser details YourSeq 225 12 391 2000 86.5% chr11 + 48701890 48702279 390 browser details YourSeq 196 12 375 2000 83.2% chr6 + 47934495 47934823 329 browser details YourSeq 186 7 810 2000 87.5% chr7 + 127409783 127410658 876 browser details YourSeq 174 12 385 2000 89.2% chr8 + 108186836 108187250 415 browser details YourSeq 172 9 404 2000 87.3% chr2 + 125237545 125237937 393 browser details YourSeq 168 15 410 2000 88.0% chr15 + 98624104 98624558 455 browser details YourSeq 167 12 405 2000 84.6% chr6 + 71472703 71473090 388 browser details YourSeq 167 11 407 2000 85.8% chr18 + 73670125 73670496 372 browser details YourSeq 167 55 407 2000 84.4% chr1 + 169835948 169836288 341 browser details YourSeq 167 51 407 2000 83.1% chr1 + 152918409 152918753 345 browser details YourSeq 165 11 397 2000 80.9% chr7 - 109666236 109666578 343 browser details YourSeq 164 53 407 2000 82.8% chr4 - 94612213 94612585 373 browser details YourSeq 164 11 408 2000 86.1% chr19 + 54461297 54461703 407 browser details YourSeq 163 11 416 2000 84.5% chr4 + 156206978 156207374 397 browser details YourSeq 161 44 384 2000 90.9% chr14 + 58375780 58376221 442 browser details YourSeq 160 14 393 2000 80.1% chr7 + 46035516 46035829 314 browser details YourSeq 157 14 397 2000 80.6% chr4 - 152682694 152683052 359 browser details YourSeq 156 11 373 2000 82.2% chr7 - 80267839 80268174 336 browser details YourSeq 156 11 397 2000 88.3% chr1 - 151725604 151725998 395 Note: The 2000 bp section upstream of start codon is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr8 + 104346765 104348764 2000 browser details YourSeq 41 1902 1960 2000 88.7% chr4 + 153933769 153933828 60 browser details YourSeq 34 1877 1929 2000 73.9% chr9 - 72690999 72691041 43 browser details YourSeq 31 1869 1904 2000 94.5% chr1 - 88305792 88305828 37 browser details YourSeq 29 1854 1894 2000 78.2% chr1 + 59753535 59753571 37 browser details YourSeq 28 1932 1965 2000 91.2% chr7 - 122153561 122153594 34 browser details YourSeq 28 1411 1458 2000 69.5% chr4 - 66328952 66328991 40 browser details YourSeq 27 1941 1970 2000 96.7% chr8 - 13639779 13639809 31 browser details YourSeq 26 1939 1964 2000 100.0% chr2 - 126712986 126713011 26 browser details YourSeq 24 1427 1450 2000 100.0% chr14 - 76373560 76373583 24 browser details YourSeq 22 1877 1898 2000 100.0% chr17 - 33821086 33821107 22 browser details YourSeq 22 1941 1962 2000 100.0% chr10 - 70403165 70403186 22 browser details YourSeq 22 729 752 2000 87.0% chr1 + 60353799 60353821 23 browser details YourSeq 22 1878 1899 2000 100.0% chr1 + 56855482 56855503 22 Note: The 2000 bp section downstream of stop codon is BLAT searched against the genome. No significant similarity is found. Page 5 of 9 https://www.alphaknockout.com Gene and protein information: Cmtm3 CKLF-like MARVEL transmembrane domain containing 3 [ Mus musculus (house mouse) ] Gene ID: 68119, updated on 12-Aug-2019 Gene summary Official Symbol Cmtm3 provided by MGI Official Full Name CKLF-like MARVEL transmembrane domain containing 3 provided by MGI Primary source MGI:MGI:2447162 See related Ensembl:ENSMUSG00000031875 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as BNAS2; Cklfsf3; AI413895; 9430096L06Rik Expression Broad expression in ovary adult (RPKM 59.8), adrenal adult (RPKM 43.1) and 22 other tissues See more Orthologs human all Genomic context Location: 8; 8 D3 See Cmtm3 in Genome Data Viewer Exon count: 15 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 8 NC_000074.6 (104339383..104347672) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 8 NC_000074.5 (106864494..106871572) Chromosome 8 - NC_000074.6 Page 6 of 9 https://www.alphaknockout.com Transcript information: This gene has 8 transcripts Gene: Cmtm3 ENSMUSG00000031875 Description CKLF-like MARVEL transmembrane domain containing 3 [Source:MGI Symbol;Acc:MGI:2447162] Gene Synonyms 9430096L06Rik, BNAS2, Cklfsf3 Location Chromosome 8: 104,339,410-104,347,672 forward strand. GRCm38:CM001001.2 About this gene This gene has 8 transcripts (splice variants), 196 orthologues, 17 paralogues and is a member of 1 Ensembl protein family. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Cmtm3-201 ENSMUST00000034343.4 1616 184aa ENSMUSP00000034343.4 Protein coding CCDS22577 Q99LJ5 TSL:1 GENCODE basic APPRIS P1 Cmtm3-204 ENSMUST00000212081.1 850 184aa ENSMUSP00000148682.1 Protein coding CCDS22577 Q99LJ5 TSL:5 GENCODE basic APPRIS P1 Cmtm3-208 ENSMUST00000212948.1 523 142aa ENSMUSP00000148628.1 Protein coding - A0A1D5RM50 CDS 3' incomplete TSL:3 Cmtm3-205 ENSMUST00000212139.1 502 118aa ENSMUSP00000148338.1 Protein coding - A0A1D5RLE8 CDS 3' incomplete TSL:5 Cmtm3-202 ENSMUST00000211885.1 465 82aa ENSMUSP00000148513.1 Protein coding - A0A1D5RLU9 CDS 3' incomplete TSL:3 Cmtm3-207 ENSMUST00000212734.1 867 No protein - Retained intron - - TSL:2 Cmtm3-206 ENSMUST00000212399.1 790 No protein - Retained intron - - TSL:2 Cmtm3-203 ENSMUST00000211996.1 630 No protein - Retained intron - - TSL:3 Page 7 of 9 https://www.alphaknockout.com 28.26 kb Forward strand 104.33Mb 104.34Mb 104.35Mb Genes (Comprehensive set... Cmtm2b-201 >protein coding Cmtm3-205 >protein coding Cmtm3-207 >retained intron Cmtm2b-202 >protein coding Cmtm3-204 >protein coding Cmtm3-202 >protein coding Cmtm3-208 >protein coding Cmtm3-203 >retained intron Cmtm3-201 >protein coding Cmtm3-206 >retained intron Contigs < AC121952.4 Genes < Cmtm4-201protein coding (Comprehensive set... Regulatory Build 104.33Mb 104.34Mb 104.35Mb Reverse strand 28.26 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Gene Legend Protein Coding Ensembl protein coding merged Ensembl/Havana Non-Protein Coding processed transcript Page 8 of 9 https://www.alphaknockout.com Transcript: ENSMUST00000034343 7.08 kb Forward strand Cmtm3-201 >protein coding ENSMUSP00000034... Transmembrane heli... MobiDB lite Low complexity (Seg) Pfam Marvel domain PROSITE profiles Marvel domain PANTHER PTHR22776 PTHR22776:SF3 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend synonymous variant Scale bar 0 20 40 60 80 100 120 140 160 184 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 9 of 9.
Load more

Recommended publications
  • Genome-Wide DNA Methylation Analysis of KRAS Mutant Cell Lines Ben Yi Tew1,5, Joel K
    www.nature.com/scientificreports OPEN Genome-wide DNA methylation analysis of KRAS mutant cell lines Ben Yi Tew1,5, Joel K. Durand2,5, Kirsten L. Bryant2, Tikvah K. Hayes2, Sen Peng3, Nhan L. Tran4, Gerald C. Gooden1, David N. Buckley1, Channing J. Der2, Albert S. Baldwin2 ✉ & Bodour Salhia1 ✉ Oncogenic RAS mutations are associated with DNA methylation changes that alter gene expression to drive cancer. Recent studies suggest that DNA methylation changes may be stochastic in nature, while other groups propose distinct signaling pathways responsible for aberrant methylation. Better understanding of DNA methylation events associated with oncogenic KRAS expression could enhance therapeutic approaches. Here we analyzed the basal CpG methylation of 11 KRAS-mutant and dependent pancreatic cancer cell lines and observed strikingly similar methylation patterns. KRAS knockdown resulted in unique methylation changes with limited overlap between each cell line. In KRAS-mutant Pa16C pancreatic cancer cells, while KRAS knockdown resulted in over 8,000 diferentially methylated (DM) CpGs, treatment with the ERK1/2-selective inhibitor SCH772984 showed less than 40 DM CpGs, suggesting that ERK is not a broadly active driver of KRAS-associated DNA methylation. KRAS G12V overexpression in an isogenic lung model reveals >50,600 DM CpGs compared to non-transformed controls. In lung and pancreatic cells, gene ontology analyses of DM promoters show an enrichment for genes involved in diferentiation and development. Taken all together, KRAS-mediated DNA methylation are stochastic and independent of canonical downstream efector signaling. These epigenetically altered genes associated with KRAS expression could represent potential therapeutic targets in KRAS-driven cancer. Activating KRAS mutations can be found in nearly 25 percent of all cancers1.
    [Show full text]
  • Análise Integrativa De Perfis Transcricionais De Pacientes Com
    UNIVERSIDADE DE SÃO PAULO FACULDADE DE MEDICINA DE RIBEIRÃO PRETO PROGRAMA DE PÓS-GRADUAÇÃO EM GENÉTICA ADRIANE FEIJÓ EVANGELISTA Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas Ribeirão Preto – 2012 ADRIANE FEIJÓ EVANGELISTA Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas Tese apresentada à Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo para obtenção do título de Doutor em Ciências. Área de Concentração: Genética Orientador: Prof. Dr. Eduardo Antonio Donadi Co-orientador: Prof. Dr. Geraldo A. S. Passos Ribeirão Preto – 2012 AUTORIZO A REPRODUÇÃO E DIVULGAÇÃO TOTAL OU PARCIAL DESTE TRABALHO, POR QUALQUER MEIO CONVENCIONAL OU ELETRÔNICO, PARA FINS DE ESTUDO E PESQUISA, DESDE QUE CITADA A FONTE. FICHA CATALOGRÁFICA Evangelista, Adriane Feijó Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas. Ribeirão Preto, 2012 192p. Tese de Doutorado apresentada à Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo. Área de Concentração: Genética. Orientador: Donadi, Eduardo Antonio Co-orientador: Passos, Geraldo A. 1. Expressão gênica – microarrays 2. Análise bioinformática por module maps 3. Diabetes mellitus tipo 1 4. Diabetes mellitus tipo 2 5. Diabetes mellitus gestacional FOLHA DE APROVAÇÃO ADRIANE FEIJÓ EVANGELISTA Análise integrativa de perfis transcricionais de pacientes com diabetes mellitus tipo 1, tipo 2 e gestacional, comparando-os com manifestações demográficas, clínicas, laboratoriais, fisiopatológicas e terapêuticas.
    [Show full text]
  • Role of RUNX1 in Aberrant Retinal Angiogenesis Jonathan D
    Page 1 of 25 Diabetes Identification of RUNX1 as a mediator of aberrant retinal angiogenesis Short Title: Role of RUNX1 in aberrant retinal angiogenesis Jonathan D. Lam,†1 Daniel J. Oh,†1 Lindsay L. Wong,1 Dhanesh Amarnani,1 Cindy Park- Windhol,1 Angie V. Sanchez,1 Jonathan Cardona-Velez,1,2 Declan McGuone,3 Anat O. Stemmer- Rachamimov,3 Dean Eliott,4 Diane R. Bielenberg,5 Tave van Zyl,4 Lishuang Shen,1 Xiaowu Gai,6 Patricia A. D’Amore*,1,7 Leo A. Kim*,1,4 Joseph F. Arboleda-Velasquez*1 Author affiliations: 1Schepens Eye Research Institute/Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, 20 Staniford St., Boston, MA 02114 2Universidad Pontificia Bolivariana, Medellin, Colombia, #68- a, Cq. 1 #68305, Medellín, Antioquia, Colombia 3C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114 4Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, 243 Charles St., Boston, MA 02114 5Vascular Biology Program, Boston Children’s Hospital, Department of Surgery, Harvard Medical School, 300 Longwood Ave., Boston, MA 02115 6Center for Personalized Medicine, Children’s Hospital Los Angeles, Los Angeles, 4650 Sunset Blvd, Los Angeles, CA 90027, USA 7Department of Pathology, Harvard Medical School, 25 Shattuck St., Boston, MA 02115 Corresponding authors: Joseph F. Arboleda-Velasquez: [email protected] Ph: (617) 912-2517 Leo Kim: [email protected] Ph: (617) 912-2562 Patricia D’Amore: [email protected] Ph: (617) 912-2559 Fax: (617) 912-0128 20 Staniford St. Boston MA, 02114 † These authors contributed equally to this manuscript Word Count: 1905 Tables and Figures: 4 Diabetes Publish Ahead of Print, published online April 11, 2017 Diabetes Page 2 of 25 Abstract Proliferative diabetic retinopathy (PDR) is a common cause of blindness in the developed world’s working adult population, and affects those with type 1 and type 2 diabetes mellitus.
    [Show full text]
  • Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened.
    [Show full text]
  • Supplementary Figures and Tables
    SUPPLEMENTARY DATA Supplementary Figure 1. Isolation and culture of endothelial cells from surgical specimens of FVM. (A) Representative pre-surgical fundus photograph of a right eye exhibiting a FVM encroaching on the optic nerve (dashed line) causing tractional retinal detachment with blot hemorrhages throughout retina (arrow heads). (B) Magnetic beads (arrows) allow for separation and culturing of enriched cell populations from surgical specimens (scale bar = 100 μm). (C) Cultures of isolated cells stained positively for CD31 representing a successfully isolated enriched population (scale bar = 40 μm). ©2017 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-1035/-/DC1 SUPPLEMENTARY DATA Supplementary Figure 2. Efficient siRNA knockdown of RUNX1 expression and function demonstrated by qRT-PCR, Western Blot, and scratch assay. (A) RUNX1 siRNA induced a 60% reduction of RUNX1 expression measured by qRT-PCR 48 hrs post-transfection whereas expression of RUNX2 and RUNX3, the two other mammalian RUNX orthologues, showed no significant changes, indicating specificity of our siRNA. Functional inhibition of Runx1 signaling was demonstrated by a 330% increase in insulin-like growth factor binding protein-3 (IGFBP3) RNA expression level, a known target of RUNX1 inhibition. Western blot demonstrated similar reduction in protein levels. (B) siRNA- 2’s effect on RUNX1 was validated by qRT-PCR and western blot, demonstrating a similar reduction in both RNA and protein. Scratch assay demonstrates functional inhibition of RUNX1 by siRNA-2. ns: not significant, * p < 0.05, *** p < 0.001 ©2017 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db16-1035/-/DC1 SUPPLEMENTARY DATA Supplementary Table 1.
    [Show full text]
  • MOCHI Enables Discovery of Heterogeneous Interactome Modules in 3D Nucleome
    Downloaded from genome.cshlp.org on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press MOCHI enables discovery of heterogeneous interactome modules in 3D nucleome Dechao Tian1,# , Ruochi Zhang1,# , Yang Zhang1, Xiaopeng Zhu1, and Jian Ma1,* 1Computational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA 15213, USA #These two authors contributed equally *Correspondence: [email protected] Contact To whom correspondence should be addressed: Jian Ma School of Computer Science Carnegie Mellon University 7705 Gates-Hillman Complex 5000 Forbes Avenue Pittsburgh, PA 15213 Phone: +1 (412) 268-2776 Email: [email protected] 1 Downloaded from genome.cshlp.org on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press Abstract The composition of the cell nucleus is highly heterogeneous, with different constituents forming complex interactomes. However, the global patterns of these interwoven heterogeneous interactomes remain poorly understood. Here we focus on two different interactomes, chromatin interaction network and gene regulatory network, as a proof-of-principle, to identify heterogeneous interactome modules (HIMs), each of which represents a cluster of gene loci that are in spatial contact more frequently than expected and that are regulated by the same group of transcription factors. HIM integrates transcription factor binding and 3D genome structure to reflect “transcriptional niche” in the nucleus. We develop a new algorithm MOCHI to facilitate the discovery of HIMs based on network motif clustering in heterogeneous interactomes. By applying MOCHI to five different cell types, we found that HIMs have strong spatial preference within the nucleus and exhibit distinct functional properties. Through integrative analysis, this work demonstrates the utility of MOCHI to identify HIMs, which may provide new perspectives on the interplay between transcriptional regulation and 3D genome organization.
    [Show full text]
  • A Tool to Identify Coordinately Expressed Genes
    The CO-Regulation Database (CORD): A Tool to Identify Coordinately Expressed Genes John P. Fahrenbach1*, Jorge Andrade2, Elizabeth M. McNally1,3 1 Department of Medicine, The University of Chicago, Chicago, Illinois, United States of America, 2 Center for Research Informatics, The University of Chicago, Chicago, Illinois, United States of America, 3 Department of Human Genetics, The University of Chicago, Chicago, Illinois, United States of America Abstract Background: Meta-analysis of gene expression array databases has the potential to reveal information about gene function. The identification of gene-gene interactions may be inferred from gene expression information but such meta-analysis is often limited to a single microarray platform. To address this limitation, we developed a gene-centered approach to analyze differential expression across thousands of gene expression experiments and created the CO-Regulation Database (CORD) to determine which genes are correlated with a queried gene. Results: Using the GEO and ArrayExpress database, we analyzed over 120,000 group by group experiments from gene microarrays to determine the correlating genes for over 30,000 different genes or hypothesized genes. CORD output data is presented for sample queries with focus on genes with well-known interaction networks including p16 (CDKN2A), vimentin (VIM), MyoD (MYOD1). CDKN2A, VIM, and MYOD1 all displayed gene correlations consistent with known interacting genes. Conclusions: We developed a facile, web-enabled program to determine gene-gene correlations across different gene expression microarray platforms. Using well-characterized genes, we illustrate how CORD’s identification of co-expressed genes contributes to a better understanding a gene’s potential function. The website is found at http://cord-db.org.
    [Show full text]
  • Characterization and Expression Profile of CMTM3/CKLFSF3
    Journal of Biochemistry and Molecular Biology, Vol. 39, No. 5, September 2006, pp. 537-545 Characterization and Expression Profile of CMTM3/CKLFSF3 Ji Zhong, Yu Wang, Xiaoyan Qiu, Xiaoning Mo, Yanan Liu, Ting Li, Quansheng Song, Dalong Ma and Wenling Han* Peking University Center for Human Disease Genomics, 38 Xueyuan Road, Beijing 100083, China Received 22 February 2006, Accepted 10 May 2006 CMTM/CKLFSF is a novel family of proteins linking Introduction chemokines and TM4SF. In humans, these proteins are encoded by nine genes, CKLF and CMTM1-8/CKLFSF1-8. CKLFSF is a novel family of proteins linking chemokines and Here we report the characteristics and expression profile Transmembrane 4 Super Family (TM4SF), which are encoded of CMTM3/CKLFSF3. Human CMTM3/CKLFSF3 has a by nine genes, CKLF and CKLFSF1-8, in humans. CKLF, high sequence identity among various species and similar CKLFSF1, and CKLFSF2 are active during evolution, and characteristics as its mouse and rat homologues. Established CKLFSF2 has two orthologues in rat and mouse designated by results both of RT-PCR and Quantitative Real-time Cklfsf2a and Cklfsf2b. CKLFSF3-8 are evolutionarily conserved. PCR, the gene is highly transcribed in testis, leukocytes CKLFSF members form two gene clusters: CKLF and and spleen. For further verification, we generated a CKLFSF1-4 at chromosome 16q22.1, and CKLFSF6-8 at polyclonal antibody against human CMTM3/CKLFSF3 chromosome 3p23. Most CKLFSFs have different spliced and found that the protein is highly expressed in the testis forms, and the protein product of at least one spliced form of and some cells of PBMCs.
    [Show full text]
  • A Cortical Immune Network Map Identifies a Subset of Human Microglia Involved in Tau Pathology
    bioRxiv preprint doi: https://doi.org/10.1101/234351; this version posted December 14, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. A cortical immune network map identifies a subset of human microglia involved in Tau pathology Ellis Patrick1,2*, Marta Olah3*, Mariko Taga3*, Hans-Ulrich Klein3, Jishu Xu4, Charles C White4, Daniel Felsky3, Chris Gaiteri5, Lori B Chibnik4,6, Sara Mostafavi7,8, Julie A Schneider5, David A Bennett5, Elizabeth M Bradshaw3*, Philip L De Jager3*. 1 School of Mathematics and Statistics, The University of Sydney, Sydney, Australia 2 The Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia 3 Center for Translational & Computational Neuroimmunology, Department of Neurology, Columbia University Medical Center, New York City, NY, USA 4 Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA 5 Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, Illinois, USA 6 Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA 7 Departments of Statistics and Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada. 8 Centre for Molecular Medicine and Therapeutics, Vancouver, British Columbia, Canada. *Contributed equally Correspondence should be addressed to PLD ([email protected]) Abstract Microglial dysfunction has been proposed as one of the many cellular mechanisms that can contribute to the development of Alzheimer’s disease (AD). Here, using a transcriptional network map of the human frontal cortex, we identify five gene modules of co-expressed genes related to microglia and assess their role in the neuropathologic features of AD in 541 subjects from two cohort studies of brain aging.
    [Show full text]
  • GSKB: a Gene Set Database for Pathway Analysis in Mouse
    bioRxiv preprint doi: https://doi.org/10.1101/082511; this version posted October 24, 2016. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. GSKB: A gene set database for pathway analysis in mouse Liming Lai1, Jason Hennessey1, Valerie Bares1, Eun Woo Son1, Yuguang Ban1, Wei Wang1, Jianli Qi1, Gaixin Jiang1, Arthur Liberzon2, and Steven Xijin Ge1* 1Department of Mathematics and Statistics, South Dakota State University, Brookings, SD 57007, USA 2Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA * Corresponding author: Tel: +1-605-688-5845; Email: [email protected] ABSTRACT: Interpretation of high-throughput genomics data based on biological pathways constitutes a constant challenge, partly because of the lack of supporting pathway database. In this study, we created a functional genomics knowledgebase in mouse, which includes 33,261 pathways and gene sets compiled from 40 sources such as Gene Ontology, KEGG, GeneSetDB, PANTHER, microRNA and transcription factor target genes, etc. In addition, we also manually collected and curated 8,747 lists of differentially expressed genes from 2,526 published gene expression studies to enable the detection of similarity to previously reported gene expression signatures. These two types of data constitute a Gene Set Knowledgebase (GSKB), which can be readily used by various pathway analysis software such as gene set enrichment analysis (GSEA). Using our knowledgebase, we were able to detect the correct microRNA (miR-29) pathway that was suppressed using antisense oligonucleotides and confirmed its role in inhibiting fibrogenesis, which might involve upregulation of transcription factor SMAD3.
    [Show full text]
  • High-Risk Oral Leukoplakia Is Associated with Aberrant Promoter
    Abe et al. BMC Cancer (2016) 16:350 DOI 10.1186/s12885-016-2371-5 RESEARCHARTICLE Open Access High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes Masanobu Abe1,2*, Satoshi Yamashita3, Yoshiyuki Mori4, Takahiro Abe1, Hideto Saijo1, Kazuto Hoshi1, Toshikazu Ushijima3 and Tsuyoshi Takato1 Abstract Background: Early detection of oral squamous cell carcinomas (OSCCs) is urgently needed to improve the prognosis and quality of life (QOL) of patients. Oral leukoplakias (OLs), known as the most common premalignant lesions in the oral cavity, often precede OSCCs. Especially, OLs with dysplasia are known to have a high risk of malignant transformation. Here, we searched for the promoter methylation characteristic of high-risk OLs. Methods: To identify methylation-silenced genes, a combined analysis of methylated DNA immunoprecipitation (MeDIP) − CpG island (CGI) microarray analysis and expression microarray analysis after treatment with a demethylating agent was performed in two OSCC cell lines (Ca9–22 and HSC-2). The methylation statuses of each gene were examined by methylation-specific PCR. Results: A total of 52 genes were identified as candidates for methylation-silenced genes in Ca9-22 or HSC-2. The promoter regions of 13 genes among the 15 genes randomly selected for further analysis were confirmed to be methylated in one or more of five cell lines. In OSCC tissues (n = 26), 8 of the 13 genes, TSPYL5, EGFLAM, CLDN11, NKX2-3, RBP4, CMTM3, TRPC4, and MAP6, were methylated. In OL tissues (n = 24), seven of the eight genes, except for EGFLAM, were found to be methylated in their promoter regions.
    [Show full text]
  • Supplemental Data
    Supplementary Table 1. Gene sets from Figure 6. Lists of genes from each individual gene set defined in Figure 6, including the fold-change in expression of each gene in treatment group pair-wise comparisons. ENSEMBL: Ensembl gene identifier; Symbol: official gene symbol; logFC: log fold change; p value: significance of fold-change in a pair-wise comparison, P<0.05 cut-off; FDR: false discovery rate, expected proportion of false positives among the differentially expressed genes in a pair-wise comparison (FDR<0.25 cut-off). Sup. Table 1 SET I CP versus Sal CP versus CP+DCA DCA versus Sal ENSEMBL Symbol logFC PValue FDR logFC PValue FDR logFC PValue FDR Desc ENSMUSG00000020326 Ccng1 2.64 0.00 0.00 -0.06 0.13 0.96 0.40 0.00 0.23 cyclin G1 [Source:MGI Symbol;Acc:MGI:102890] ENSMUSG00000031886 Ces2e 3.97 0.00 0.00 -0.24 0.02 0.28 0.01 1.00 1.00 carboxylesterase 2E [Source:MGI Symbol;Acc:MGI:2443170] ENSMUSG00000041959 S100a10 2.31 0.00 0.00 -0.21 0.02 0.23 -0.11 0.53 1.00 S100 calcium binding protein A10 (calpactin) [Source:MGI Symbol;Acc:MGI:1339468] ENSMUSG00000092341 Malat1 1.09 0.00 0.00 -0.11 0.20 1.00 0.66 0.00 0.00 metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA) [Source:MGI Symbol;Acc:MGI:1919539] ENSMUSG00000072949 Acot1 1.73 0.00 0.00 -0.22 0.01 0.12 -0.44 0.01 1.00 acyl-CoA thioesterase 1 [Source:MGI Symbol;Acc:MGI:1349396] ENSMUSG00000064339 mt-Rnr2 1.09 0.00 0.00 -0.08 0.17 1.00 0.67 0.00 0.07 mitochondrially encoded 16S rRNA [Source:MGI Symbol;Acc:MGI:102492] ENSMUSG00000025934 Gsta3 1.86 0.00 0.00 -0.28
    [Show full text]